Endoscopic Ultrasound GASTROINTESTINAL & HEPATOLOGY SOLUTIONS

DIAGNOSING HEPATOPANCREATICOBILIARY DISEASE

As many as 81% of new diagnoses of hepatopancreaticobiliary (HPB) disease are made in the later stages of disease progression.1 The average survival time from pancreatic cancer is low. According to the American Cancer Society, for all stages of pancreatic cancer combined, the five-year survival rate is 8.5%.1 Because of this, early diagnosis is crucial.


BEACON EUS DELIVERY SYSTEM

Product image of Medtronic Beacon EUS Delivery System against a navy blue background

The Beacon™ EUS delivery system enables fast needle exchange without changing scope position, resulting in reduced procedural time when multiple devices are used.3

  • The Beacon™ FNF needle’s pre-loaded feature simplifies the procedure, reduces overall procedure time, and reduces potential needlestick exposure for ancillary staff.4
  • The SharkCore™ FNB needle features unique needle tip geometry engineered to collect core tissue samples to improve diagnostic yield.5-8

1

SEER Cancer Statistics Factsheets: Pancreas Cancer. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/pancreas.html Accessed February 2019.

2

American Cancer Society. Cancer Facts & Figures 2013. Atlanta: American Cancer Society;2013:25-35.

3

Enestvedt B, Maranki, J, Makipour K, Mathur M, Haluszka O. Is Two Better Than One? a Comparison of EUS-FNA Efficiency of Single- vs Multi-Needle Platforms. Gastrointestinal Endoscopy. 2013;77(5S):AB179. See BNX System DFU PN100574 20B.

4

Kohari S, Kohari T, et al. 234, Endoscopic Ultrasound (EUS)-Guided Fiducial Placement for Stereotactic Body Radiotherapy (SBRT): First Global Experience With a New 22-Guage “Pre-loaded” EUS Fiducial Needle. The American Journal of Gastroenterology, vol 110, Supplement 1 October 2015 PN1006669 & PN1006668 & RMD 1004 Rev 01 Page 5, 6, 7

5

Kandel P., Tranesh G., Nassar A., Bingham R., Raimondo M., Woodward T.A., Gomez V., Wallace M.B. EUS-quided fine needle biopsy sampling using a novel fork-tip needle: a case-control study. Gastrointest Endosc 2016 Dec; 84(6):1034-1039.

6

Rodrigues-Pinto E., Jalaj S., Grimm I.S., Baron, T.H. Impact of EUS-guided fine-needle biopsy sampling with a new core needle on the need for onsite cytopathologic assessment: a preliminary study. Gastrointest Endosc 2016 Dec; 84(6).

7

Jovani M., Abidi W.M., Lee L.S. Novel fork-tip needles versus standard needles for EUS-guided tissue acquisition from solid masses of the upper GI tract: a matched cohort study. Scand J Gastroenterol 2017 Jun-Jul;52(6-7):784-787.

8

DiMaio CJ., et al. Initial Experience with a novel EUS-guided core biopsy needle (SharkCore): results of a large North American multicenter study. Endosc Int Open 2016 Sep;4(9): E974-E979.


*

Image does not represent all components of the system